CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $322,000 | -51.4% | 274,820 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $663,000 | -17.8% | 270,444 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $807,000 | -27.4% | 269,027 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,112,000 | +2038.5% | 269,221 | +2153.1% | 0.00% | – |
| Q1 2015 | $52,000 | +79.3% | 11,949 | +21.9% | 0.00% | – |
| Q4 2014 | $29,000 | -14.7% | 9,799 | -5.0% | 0.00% | – |
| Q3 2014 | $34,000 | +36.0% | 10,313 | +4.1% | 0.00% | – |
| Q2 2014 | $25,000 | – | 9,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |